Research Areas of the Buchwald Group
The selective modification of complex biological molecules holds great promise for the develoment of new, potent therapies for a wide range of diseases. Our lab is currently exploring new methods for rapid, efficient, and selective modification for an array of complex, biologically important molecules.
Amines, aryl ethers, and other nitrogen or oxygen containing functional groups are prevalent and essential constituents of many pharmaceuticals and other biologically active compounds. We are currently pursuing the development of new, highly active catalyst systems for both carbon-nitrogen (C–N) bond formation and carbon-oxygen (C–O) bond formation.
Transition metal-catalyzed systems offer a straightforward route for the formation of carbon−carbon bonds. Suzuki−Miyaura, Heck, and Negishi cross coupling are all classical methods for introducing molecular complexity and for simplifying the synthesis of desired targets. Our lab is interested in the continued development of systems for carbon−carbon bond formation. Much of this work relies on the practicality and robustness of the approach, which is often achieved through mechanistic understanding, ligand design and catalyst development.
The development of methods for the construction of organofluorine compounds is of great importance due to the broad presence of fluorine in pharmaceuticals and agrochemicals. Fluorine substitution markedly changes the properties and behavior of the molecule (i.e. lipophilicity, cell membrane permeability, drug potency, and half-life time in the body). Thus, significant efforts have been made towards the development of new fluorination systems.
The development of safe, scalable processes is critically important for the manufacture of pharmaceuticals. Our lab is actively engaged in the development of new continuous flow processes.
Catalysts that are derived from earth-abundant materials and display unique reactivity are of interest to the synthetic and the chemistry community as a whole. Although copper(I) hydride was discovered in the 1840s and widely applied in organic synthesis since the 1980s, the potential of a catalytic system has not been fully realized, and several reports in the past few years have demonstrated the applicability of this area of work. Our laboratory is interested in discovering new processes and applications that are catalyzed by copper(I) hydride complexes.